dalteparin has been researched along with ACA Infarct in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dechambre, S | 1 |
| Duprez, T | 1 |
| Cosnard, G | 1 |
1 other study available for dalteparin and ACA Infarct
| Article | Year |
|---|---|
Images in clinical radiology. Updated MR work-up of hyperacute stroke.
Topics: Aspirin; Echo-Planar Imaging; Fibrinolytic Agents; Humans; Image Enhancement; Infarction, Anterior C | 1999 |